Search Orphan Drug Designations and Approvals
-
Generic Name: | 2-(2-phenylvinyl)-4-[4-methylpiperazin-1-yl)]-6-(5-methyl-2H-pyrazol-3-yl-amino)-pyrimidine L(+) tartrate salt |
---|---|
Date Designated: | 07/01/2014 |
Orphan Designation: | Treatment of hepatocellular carcinoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
CASI Pharmaceuticals, Inc. 9620 Medical Center Drive Suite 300 Rockville, Maryland 20850 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-